Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Details for Australian Patent Application No. 2004257288 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Pitlik, Janos; Cottrell, Kevin M.; Britt, Shawn D.; Perni, Robert B.

Agent Cullen & Co

Pub. Number AU-A-2004257288

PCT Pub. Number WO2005/007681

Priority 60/488,535 18.07.03 US

Filing date 16 July 2004

Wipo publication date 27 January 2005

International Classifications

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/007681 Priority application(s): WO2005/007681

26 June 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 28 Apr 2008

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257289-Biaryl piperazinyl-pyridine analogues

2004257277-Substituted arylthiourea derivatives useful as inhibitors of viral replication